Does Myomectomy for Intramural Fibroid Improve ART Outcome?

NCT03796130 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-12-16

No results posted yet for this study

Summary

Intamural fibroids (myoma) do exist in some infertile women undergoing IVF treatment. There is controversy whether myomectomy before IVF treatment could improve IVF outcome. This trial will examine whether myomectomy in those patients could improve the results.

Conditions

  • Fibroid Uterus

Interventions

PROCEDURE

Myomectomy

This study will include women who have intramural myomas ranging from 3-5 cm The participants will be randomly allocated into two groups. In group (1): myomectomy will be performed before ART In group (2):women will have their trial of ART without myomectomy In group A, ART will be performed 3 months after myomectomy if the uterine cavity is not opened and 6 months after myomectomy upon inadvertent opening of the uterine cavity during surgery

Sponsors & Collaborators

  • Alexandria University

    collaborator OTHER
  • Zagazig University

    collaborator OTHER_GOV
  • Sohag University

    collaborator OTHER
  • Assiut University

    collaborator OTHER
  • Mansoura University

    lead OTHER

Principal Investigators

  • Ahmed Gibreel, MD · Mansoura University

  • Mohamed S Abdelhafez, MD · Mansoura University

  • Salah Rasheed, MD · Sohag University

  • Ahmed Nasr, MD · Assiut Universit

  • Hisham A Saleh, MD · Alexandria University

  • Hassan El Maghraby, MD · Alexandria University

  • Eman El Gindy, MD · Zagazig University

  • Hoda Sibai, MD · Zagazig University

  • Hamed Yossef, MD · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796130 on ClinicalTrials.gov